Adeberg, S. ., Bernhardt, D. ., Harrabi, S. ., Nicolay, N. ., Hörner-Rieber, J. ., König, L. ., … Rieken, S. . (2017). Metformin Enhanced <i>in Vitro</i> Radiosensitivity Associates with G2/M Cell Cycle Arrest and Elevated Adenosine-5’-monophosphate-activated Protein Kinase Levels in Glioblastoma. Radiology and Oncology, 51(4), 431-437. https://doi.org/10.1515/raon-2017-0042

Christopoulos, P. ., , Bozorgmehr, F. ., Elsayed, M. ., Kirchner, M. ., Ristau, J. ., … Thomas, M. . (2018). EML4-ALK fusion variant V3 is a high-risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK⁺ NSCLC. International Journal of Cancer. https://doi.org/10.1002/ijc.31275 (Original work published 2018)

Bernhardt, D. ., König, L. ., Aufderstrasse, S. ., Krisam, J. ., Hoerner-Rieber, J. ., Adeberg, S. ., … Rieken, S. . (2017). Generation of a New Disease-specific Prognostic Score for Patients With Brain Metastases From Small-cell Lung Cancer Treated With Whole Brain Radiotherapy (BMS-Score) and Validation of Two Other Indices. Clinical Lung Cancer. https://doi.org/10.1016/j.cllc.2017.12.004 (Original work published 2017)